BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14871977)

  • 1. Molecular serological detection of DNA alterations in transitional cell carcinoma is highly sensitive and stage independent.
    von Knobloch R; Brandt H; Schrader AJ; Heidenreich A; Hofmann R
    Clin Cancer Res; 2004 Feb; 10(3):988-93. PubMed ID: 14871977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular serological diagnosis in transitional cell bladder cancer.
    von Knobloch R; Brandt H; Hofmann R
    Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis.
    von Knobloch R; Hegele A; Brandt H; Olbert P; Heidenreich A; Hofmann R
    Int J Cancer; 2001 Oct; 94(1):67-72. PubMed ID: 11668480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of serum DNA alterations in renal cell carcinoma detected by fluorescent microsatellite analysis.
    von Knobloch R; Hegele A; Brandt H; Varga Z; Wille S; Kälble T; Heidenreich A; Hofmann R
    Int J Cancer; 2002 Apr; 98(6):889-94. PubMed ID: 11948468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic pathways and new progression markers for prostate cancer suggested by microsatellite allelotyping.
    von Knobloch R; Konrad L; Barth PJ; Brandt H; Wille S; Heidenreich A; Moll R; Hofmann R
    Clin Cancer Res; 2004 Feb; 10(3):1064-73. PubMed ID: 14871986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
    Erbersdobler A; Friedrich MG; Schwaibold H; Henke RP; Huland H
    Oncol Res; 1998; 10(8):415-20. PubMed ID: 10100758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
    Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
    J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
    Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
    J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients.
    Beau-Faller M; Gaub MP; Schneider A; Ducrocq X; Massard G; Gasser B; Chenard MP; Kessler R; Anker P; Stroun M; Weitzenblum E; Pauli G; Wihlm JM; Quoix E; Oudet P
    Int J Cancer; 2003 Jun; 105(3):361-70. PubMed ID: 12704670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma.
    Cussenot O; Sighar K; Mohammed M; Hugonin S; Ondet V; Larre S; Lacave R; Roupret M; Cancel-Tassin G
    World J Urol; 2014 Apr; 32(2):551-7. PubMed ID: 24196429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.
    Turyn J; Matuszewski M; Schlichtholz B
    Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocality of transitional cell carcinoma results from genetic instability of entire transitional epithelium.
    Pycha A; Mian C; Hofbauer J; Brössner C; Haitel A; Wiener H; Marberger M
    Urology; 1999 Jan; 53(1):92-7. PubMed ID: 9886595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial allelotype of schistosomiasis-associated bladder cancer.
    Shaw ME; Elder PA; Abbas A; Knowles MA
    Int J Cancer; 1999 Mar; 80(5):656-61. PubMed ID: 10048962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
    Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
    Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer.
    El-Rifai W; Kamel D; Larramendy ML; Shoman S; Gad Y; Baithun S; El-Awady M; Eissa S; Khaled H; Soloneski S; Sheaff M; Knuutila S
    Am J Pathol; 2000 Mar; 156(3):871-8. PubMed ID: 10702404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder.
    Kimura F; Florl AR; Seifert HH; Louhelainen J; Maas S; Knowles MA; Schulz WA
    Br J Cancer; 2001 Dec; 85(12):1887-93. PubMed ID: 11747331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From cytogenetics to cytogenomics of bladder cancers].
    Léonard C; Huret JL; Gfco ;
    Bull Cancer; 2002 Feb; 89(2):166-73. PubMed ID: 11888856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelotype of human bladder cancer.
    Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
    Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma.
    Bartoletti R; Cai T; Dal Canto M; Boddi V; Nesi G; Piazzini M
    J Urol; 2006 Jun; 175(6):2032-7; discussion 2037. PubMed ID: 16697794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.